Adenovirus is a common virus that causes infectious diseases of the respiratory tract, eyes and gastrointestinal tract in humans and animals. Researchers at Umeå University study molecular mechanisms of infection in order to understand how adenovirus causes disease.
The researchers in Umeå, together with research groups from Germany, the UK and Hungary, have now discovered a new type of mechanism used by a rare adenovirus type to attack cells.
Human Adenovirus type 52 (HAdV-52) is one of the few adenoviruses that has two different types of fiber proteins on its surface, which are ‘used’ by the virus for the attachment to target cells. In collaboration with researchers in the Glycosciences Laboratory at Imperial College in London, who are world leading in the research field of glycobiology, the scientists have shown that the shorter fiber binds to an unusual type of carbohydrate-based receptor, polysialic acid (a long chain of repeated sialic acids). Annasara Lenman working with Niklas Arnberg has subsequently corroborated that HAdV-52 binds to polysialic acid on target cells, and that this leads to infection. In collaboration with experts in structural biology at the University of Tübingen, the interaction between the short fiber and polysialic acid has been mapped at the atomic level.
“We knew earlier that the short fiber binds to sialic acid, but not how the underlying carbohydrate chain was constructed,” explains Annasara Lenman postdoc at the Department of Clinical Microbiology and The Laboratory for Molecular Infection Medicine Sweden (MIMS) at Umeå University.
As polysialic acid is overexpressed on cancer cells in the brain and lungs, our findings could open new possibilities to use HAdV-52 for treatment for the corresponding types of cancer.
For a long time, adenovirus and other viruses have been considered suitable weapons for the treatment of different types of cancer. Viruses can kill cancer cells themselves, but in recent years it has also been understood that a virus infection in a tumor can activate the immune system against the cancer cells. You can also “arm” viruses with different genes that can for example counteract the development of resistance against different drugs. A major challenge has been to target viruses specifically against the cancer cells.
“Most adenoviruses tested so far have only one type of cell-binding fiber. HAdV-52 has two different fibers, one of which has a natural predilection for cancerous cells that express polysialic acid. This opens up a more effective harnessing of viruses against the right kind of cells”, Annasara Lenman explains.
The results can also be of importance in other research areas:
“Perhaps the most important function of polysialic acid is its contribution to the brain’s development. However, one has not known much about how polysialic acid interacts with its environment. Our research makes it pertinent to investigate whether polysialic acidplays a part in brain development by interacting with specific cellular molecules.” says Annasara Lenman.
The Latest on: Adenovirus
via Google News
The Latest on: Adenovirus
- Are more long-term facilities needed for New Jersey’s sickest kids? on April 16, 2019 at 3:03 pm
An attorney represented several families whose children survived an infectious adenovirus — that sickening dozens and killed 11 patients — that roared unchecked through the Wanaque Center for Nursing ... […]
- Enesi and Oxford University look to create first effective plague vaccine on April 16, 2019 at 3:32 am
The scientists will try to formulate Oxford Vaccine Group (OVG)’s ‘chimpanzee adenovirus Oxford’ (ChAdOx) vector into Enesi’s ImplaVax technology, aiming to create a vaccine against the plague ... […]
- HCV vaccine using chimp adenovirus shows promise in healthy humans on April 12, 2019 at 12:47 pm
VIENNA — Use of adenovirus derived from chimpanzees showed increased activity and sustainability of T cell activation in an early study of a vaccine for hepatitis C virus, according to new data ... […]
- Vaxart to Present at the 29th European Congress of Clinical Microbiology & Infectious Diseases on April 12, 2019 at 5:00 am
Details of the presentation are as follows: Poster Title: Oral adenovirus-based quadrivalent influenza vaccine protects ferrets from lethal challenge with a pandemic H5N1 influenza virus (Vietnam H5N1 ... […]
- Enesi Pharma, University of Oxford collaborate to target plague with novel ImplaVax-enabled adenovirus-based solid dose vaccine on April 11, 2019 at 5:30 am
Enesi Pharma, an innovative pharmaceutical company developing unique injectable solid dose drug-device vaccine products and scientists at the world-renowned Oxford Vaccine Group (OVG) at the ... […]
- Enesi Pharma and University of Oxford Collaborate to Target Plague With a Novel ImplaVax®-enabled Adenovirus-based Solid Dose Vaccine on April 9, 2019 at 1:00 am
OXFORD, England, April 9, 2019 /PRNewswire/ -- Enesi Pharma ("Enesi"), an innovative pharmaceutical company developing unique injectable solid dose drug-device vaccine products and scientists at the ... […]
- Global Adenovirus Vaccine Market 2019 Teva Pharmaceuticals on April 5, 2019 at 6:34 am
The report on the Global Adenovirus Vaccine Market offers complete data on the Adenovirus Vaccine market. Components, for example, main players, analysis, size, situation of the business, SWOT ... […]
- Respiratory Adenovirus Infection, 'Mild Respiratory Disease' on April 4, 2019 at 5:44 am
An adenovirus infection of chickens with a morbidity of 1-10% and a mortality of 1-10%; at least 12 sero-types have been described and these may be isolated from healthy chickens. Infected birds may ... […]
- Developing A Scalable Process For Adenovirus Manufacturing on April 2, 2019 at 2:11 pm
Market analysis done by GE Healthcare in 2016 showed that viral vectors are being utilized in a number of different ways. The most commonly used viral vector at that time was the adenovirus, although ... […]
via Bing News